A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)

NCT05810948 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

BIOLOGICAL: efgartigimod IV
OTHER: Placebo

Sponsor

argenx

Collaborators

[object Object]